Current status of carotid stenting

Current Vascular Pharmacology

Volumn 6, Issue 2, 2008, Pages 143-147

  Kim, Ji Sun ^a   Mukherjee, Debabrata ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Carotid endarterectomy; Carotid stenosis; Carotid stenting; Secondary prevention

Indexed keywords

ACETYLSALICYLIC ACID; ATORVASTATIN; CLOPIDOGREL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ANTITHROMBOCYTIC AGENT;

ANGIOPLASTY; ARTERIAL WALL THICKENING; CAROTID ARTERY OBSTRUCTION; CAROTID ENDARTERECTOMY; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CRANIAL NERVE PARALYSIS; CRANIAL NEUROPATHY; DRUG INDICATION; ENDOVASCULAR SURGERY; HEALTH CENTER; HIGH RISK PATIENT; HUMAN; INTERMETHOD COMPARISON; ISCHEMIC HEART DISEASE; LONG TERM CARE; MEDICAID; MEDICARE; MORBIDITY; PERIOPERATIVE COMPLICATION; POSTMARKETING SURVEILLANCE; POSTOPERATIVE PERIOD; REVIEW; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SECONDARY PREVENTION; STENT; STROKE; SURGICAL MORTALITY; SURGICAL TECHNIQUE; THROMBOSIS; TREATMENT INDICATION; WOUND COMPLICATION;

CAROTID STENOSIS; ENDARTERECTOMY, CAROTID; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; PLATELET AGGREGATION INHIBITORS; PRODUCT SURVEILLANCE, POSTMARKETING; STENTS; STROKE;

EID: 47249123693     PISSN: 15701611     EISSN: None     Source Type: Journal    
DOI: 10.2174/157016108783955347     Document Type: Review

References (16)

1. Roffi M, Yadav JS. Carotid stenting. Circulation 2006; 114: e1-4.
2. Barnett HJ, Taylor DW, Eliasziw M, Fox AJ, Ferguson GG, Haynes RB, et al. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med 1998; 339: 1415-25.
3. Biller J, Feinberg WM, Castaldo JE, Whittemore AD, Harbaugh RE, Dempsey RJ, et al. Guidelines for carotid endarterectomy: a statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Heart Association. Circulation 1998; 97: 501-9.
4. Yadav JS, Wholey MH, Kuntz RE, Fayad P, Katzen BT, Mishkel GJ, et al. Protected carotid-artery stenting vs. endarterectomy in high-risk patients. N Engl J Med 2004; 351: 1493-501.
5. CAVATAS Investigators. Endovascular vs. surgical treatment in patients with carotid stenosis in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS): a randomised trial. Lancet 2001; 357: 1729-37.
6. Ringleb PA, Allenberg J, Bruckmann H, Eckstein HH, Fraedrich G, Hartmann M, et al. 30 day results from the SPACE trial of stent-protected angioplasty vs. carotid endarterectomy in symptomatic patients: a randomised non-inferiority trial. Lancet 2006; 368: 1239-47.
7. Mas JL, Chatellier G, Beyssen B, Branchereau A, Moulin T, Becquemin JP, et al. Endarterectomy vs. stenting in patients with symptomatic severe carotid stenosis. N Engl J Med 2006; 355: 1660-71.
8. Gray WA, Hopkins LN, Yadav S, Davis T, Wholey M, Atkinson R, et al. Protected carotid stenting in high-surgical-risk patients: the ARCHeR results. J Vasc Surg 2006; 44: 258-68.
9. Theiss T, Hermanek P, Mathias K, Ahmadi R, Heuser L, Hoffmann FJ, et al. A Prospective registry of carotid angioplasty and stenting. Stroke 2004; 35: 2134-39.
10. Gray WA, Yadav JS, Verta P, Scicli A, Fairman R, Wholey M, et al. The CAPTURE registry: results of carotid stenting with embolic protection in the post approval setting. Catheter Cardiovasc Interv 2007; 69: 341-8.
11. Amarenco P, Bogousslavsky J, Callahan A, 3rd, Goldstein LB, Hennerici M, Rudolph AE, et al. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 2006; 355: 549-59.
12. Paraskevas KI, Athyros VG, Briana DD, Kakafika AI, Karagiannis A, Mikhailidis DP. Statins exert multiple beneficial effects on patients undergoing percutaneous revascularization procedures. Current Drug Targets 2007; 8: 942-51.
13. Paraskevas KI, Hamilton G, Mikhailidis DP. Statins: an essential component in the management of carotid artery disease. J Vasc Surg 2007; 46: 373-86.
14. Paraskevas KI, Liapis CD, Hamilton G, Mikhailidis DP. Can statins reduce perioperative morbidity and mortality in patients undergoing non-cardiac vascular surgery? Eur J Vasc Endovasc Surg 2006; 32: 286-93.
15. LaMuraglia GM, Stoner MC, Brewster DC, Watkins MT, Juhola KL, Kwolek C, et al. Determinants of carotid endarterectomy anatomic durability: effects of serum lipids and lipid-lowering drugs. J Vasc Surg 2005; 41: 762-8.
16. Mukherjee D, Lingam P, Chetcuti S, Grossman PM, Moscucci M, Luciano AE, et al. Missed opportunities to treat atherosclerosis in patients undergoing peripheral vascular interventions: insights from the University of Michigan Peripheral Vascular Disease Quality Improvement Initiative (PVD-QI2). Circulation 2002; 106: 1909-12.